MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q4 2025

SEC EDGAR SourceSEC Filings

Top Holdings141 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

NVIDIA CORP

7.9M$1.5B6.9%$131.46+42.65%
28 qtrssince 2019-Q1
Increased
75

ALPHABET INC-CL A

4.5M$1.4B6.6%$105.49+197.51%
28 qtrssince 2019-Q1
Decreased
0

MICROSOFT CORP

2.9M$1.4B6.5%$229.99+111.96%
28 qtrssince 2019-Q1
Increased
62

APPLE INC

4.8M$1.3B6.1%$147.16+84.23%
28 qtrssince 2019-Q1
Decreased
0
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

39.3M$1.2B5.8%$11.66+168.82%
25 qtrssince 2019-Q4
Increased
62

AMAZON.COM INC

3.3M$770.2M3.6%$137.40+69.24%
28 qtrssince 2019-Q1
Decreased
0

BROADCOM INC

1.8M$632.2M3.0%$221.91+55.39%
5 qtrssince 2024-Q4
Increased
57
XLIXLI
ETF

INDUSTRIAL SELECT SECT SPDR

3.9M$601M2.8%$139.22+12.35%
9 qtrssince 2023-Q4
Increased
59

APPLIED MATERIALS INC

1.8M$576.5M2.7%$132.02+94.18%
20 qtrssince 2021-Q1
Increased
58

META PLATFORMS INC-CLASS A

868,165$573.1M2.7%$274.21+142.87%
23 qtrssince 2020-Q2
Increased
54
FLINFLIN
ETF

FRANKLIN TEMPLETON ETF TR

11.8M$457.1M2.1%$34.49+11.04%
11 qtrssince 2023-Q2
Increased
66
XLEXLE
ETF

ENERGY SELECT SECTOR SPDR

9.4M$419.1M2.0%$44.68+0.62%
12 qtrssince 2023-Q1
Increased
79

MASTERCARD INC - A

691,560$394.8M1.9%$341.66+68.75%
20 qtrssince 2021-Q1
Increased
49

TESLA INC

860,781$387.1M1.8%$282.32+60.96%
11 qtrssince 2023-Q2
Unchanged
0

NOVA LTD

1.2M$382.7M1.8%$49.23+582.60%
28 qtrssince 2019-Q1
Unchanged
0

JPMORGAN CHASE & CO

1.1M$356.2M1.7%$146.85+119.25%
10 qtrssince 2023-Q3
Decreased
0
XLPXLP
ETF

CONSUMER STAPLES SPDR

4.1M$320.7M1.5%$76.68+1.91%
12 qtrssince 2023-Q1
Increased
60

ELI LILLY & CO

293,800$315.7M1.5%$848.81+26.00%
6 qtrssince 2024-Q3
Unchanged
0
KBWBKBWB
ETF

INVESCO EXCH TRADED FD TR II

3.5M$299.1M1.4%$68.29+24.34%
4 qtrssince 2025-Q1
Increased
56
XLVXLV
ETF

HEALTH CARE SELECT SECTOR SPDR

1.7M$270.2M1.3%$145.11+7.28%
12 qtrssince 2023-Q1
Increased
72
$21.3B
AUM
141
Positions
Q4 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
+8%Q3'24$15.9B+1%Q4'24$16B-3%Q1'25$15.4B+13%Q2'25$17.4B+13%Q3'25$19.7B+8%Q4'25$21.3B
Activity profile
$ moved · Q4'25
New10%Increased53%Decreased19%Exited18%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 years
<1Q7%1-4Q23%1-2Y13%2Y+57%

MENORA MIVTACHIM HOLDINGS LTD. manages $21.3B across 141 positions as of Q4 2025. Top holdings: NVDA (6.9%), GOOGL (6.6%), MSFT (6.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q4 2025 Summary

Active quarter - 18 new positions, 11 exits, 60 increased. Top move: XLE (INCREASED, conviction 79). Portfolio: $21.3B across 141 positions.

Top holdings by portfolio weight

Total AUM$21B
NVDA6.92%
GOOGL6.62%
MSFT6.50%
AAPL6.10%
TEVA5.77%
AMZN3.62%
AVGO2.97%
XLI2.82%
AMAT2.71%
META2.69%
Other2.15%

Portfolio allocation by GICS sector

Sectors11
Technology34.45%
Unknown21.63%
Healthcare12.03%
Communication Services9.86%
Consumer Cyclical7.53%
Financial Services7.18%
Consumer Defensive2.96%
Industrials2.16%
Real Estate1.52%
Energy0.37%
Other0.30%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Unknown, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used